Acadian Asset Management
ESPR icon

Acadian Asset Management’s Esperion Therapeutics ESPR Stock Holding History

Acadian Asset Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$343K Buy
125,942
+114,830
+1,033% +$364K ﹤0.01% 1451
2025
Q4 		$41K Buy
+11,112
New +$35.9K ﹤0.01% 1822
2023
Q4 		– Sell
-136,346
Closed -$131K – 1707
2023
Q3 		$131K Buy
+136,346
New +$197K ﹤0.01% 1268
2020
Q2 		– Sell
-1,364
Closed -$43K – 2253
2020
Q1 		$43K Buy
+1,364
New +$72K ﹤0.01% 1532
2019
Q4 		– Sell
-3,956
Closed -$145K – 1948
2019
Q3 		$145K Sell
3,956
-13,091
-77% -$519K ﹤0.01% 1394
2019
Q2 		$793K Buy
+17,047
New +$801K ﹤0.01% 866
2016
Q4 		– Sell
-100
Closed -$1K – 1664
2016
Q3 		$1K Buy
+100
New +$1.13K ﹤0.01% 1381

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return